SomaLogic, Inc. (NASDAQ: SLGC) Stock Competitors & Peer Comparison
See SLGC's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SLGC and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SLGC | $2.10 | -8.30% | 396.2M | -3.04 | -$0.69 | N/A |
| GEHC | $73.79 | +2.09% | 33.3B | 16.18 | $4.56 | +0.19% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $60.23 | +0.92% | 11.8B | 48.57 | $1.24 | N/A |
| TEM | $54.29 | -0.59% | 9.5B | -108.58 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $105.59 | +0.09% | 8.8B | 24.67 | $4.28 | N/A |
| TXG | $58.15 | +0.69% | 7.4B | -342.06 | -$0.17 | N/A |
| HNGE | $87.42 | +1.27% | 6.8B | 46.68 | $1.87 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
SLGC vs GEHC Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, GEHC has a market cap of 33.3B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while GEHC trades at $73.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas GEHC's P/E ratio is 16.18. In terms of profitability, SLGC's ROE is -0.19%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, SLGC is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
SLGC vs GEHCV Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas GEHCV's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, SLGC is more volatile compared to GEHCV. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
SLGC vs BTSG Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, BTSG has a market cap of 11.8B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while BTSG trades at $60.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas BTSG's P/E ratio is 48.57. In terms of profitability, SLGC's ROE is -0.19%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, SLGC is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check BTSG's competition here
Tempus AI, Inc. (NASDAQ: TEM)
SLGC vs TEM Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, TEM has a market cap of 9.5B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while TEM trades at $54.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas TEM's P/E ratio is -108.58. In terms of profitability, SLGC's ROE is -0.19%, compared to TEM's ROE of -0.55%. Regarding short-term risk, SLGC is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
SLGC vs SGFY Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SGFY's P/E ratio is 70.91. In terms of profitability, SLGC's ROE is -0.19%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, SLGC is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
SLGC vs HQY Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, HQY has a market cap of 8.8B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while HQY trades at $105.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas HQY's P/E ratio is 24.67. In terms of profitability, SLGC's ROE is -0.19%, compared to HQY's ROE of +0.11%. Regarding short-term risk, SLGC is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check HQY's competition here
10x Genomics, Inc. (NASDAQ: TXG)
SLGC vs TXG Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, TXG has a market cap of 7.4B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while TXG trades at $58.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas TXG's P/E ratio is -342.06. In terms of profitability, SLGC's ROE is -0.19%, compared to TXG's ROE of -0.09%. Regarding short-term risk, SLGC is more volatile compared to TXG. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check TXG's competition here
Hinge Health, Inc. (NYSE: HNGE)
SLGC vs HNGE Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, HNGE has a market cap of 6.8B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while HNGE trades at $87.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas HNGE's P/E ratio is 46.68. In terms of profitability, SLGC's ROE is -0.19%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, SLGC is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
SLGC vs RCM Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas RCM's P/E ratio is -102.21. In terms of profitability, SLGC's ROE is -0.19%, compared to RCM's ROE of +0.00%. Regarding short-term risk, SLGC is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check RCM's competition here
Doximity, Inc. (NYSE: DOCS)
SLGC vs DOCS Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, DOCS has a market cap of 5B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while DOCS trades at $26.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas DOCS's P/E ratio is 17.38. In terms of profitability, SLGC's ROE is -0.19%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, SLGC is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check DOCS's competition here
Waystar Holding Corp. (NASDAQ: WAY)
SLGC vs WAY Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, WAY has a market cap of 4.8B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while WAY trades at $25.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas WAY's P/E ratio is 16.61. In terms of profitability, SLGC's ROE is -0.19%, compared to WAY's ROE of +0.04%. Regarding short-term risk, SLGC is more volatile compared to WAY. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check WAY's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
SLGC vs ONEM Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas ONEM's P/E ratio is -7.77. In terms of profitability, SLGC's ROE is -0.19%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, SLGC is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
SLGC vs PRVA Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, PRVA has a market cap of 2.7B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while PRVA trades at $21.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas PRVA's P/E ratio is 103.62. In terms of profitability, SLGC's ROE is -0.19%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, SLGC is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check PRVA's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
SLGC vs HTFL Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, HTFL has a market cap of 2.7B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while HTFL trades at $31.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas HTFL's P/E ratio is -15.43. In terms of profitability, SLGC's ROE is -0.19%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, SLGC is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
SLGC vs WGS Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, WGS has a market cap of 2.4B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while WGS trades at $79.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas WGS's P/E ratio is 219.86. In terms of profitability, SLGC's ROE is -0.19%, compared to WGS's ROE of -0.39%. Regarding short-term risk, SLGC is more volatile compared to WGS. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check WGS's competition here
Progyny, Inc. (NASDAQ: PGNY)
SLGC vs PGNY Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, PGNY has a market cap of 2B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while PGNY trades at $25.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas PGNY's P/E ratio is 18.76. In terms of profitability, SLGC's ROE is -0.19%, compared to PGNY's ROE of +0.16%. Regarding short-term risk, SLGC is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check PGNY's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
SLGC vs NXGN Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas NXGN's P/E ratio is -266.00. In terms of profitability, SLGC's ROE is -0.19%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, SLGC is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check NXGN's competition here
Omada Health (NASDAQ: OMDA)
SLGC vs OMDA Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while OMDA trades at $24.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas OMDA's P/E ratio is 348.14. In terms of profitability, SLGC's ROE is -0.19%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, SLGC is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
SLGC vs AGTI Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas AGTI's P/E ratio is -71.79. In terms of profitability, SLGC's ROE is -0.19%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, SLGC is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
SLGC vs GDRX Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, GDRX has a market cap of 1.3B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while GDRX trades at $3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas GDRX's P/E ratio is 11.63. In terms of profitability, SLGC's ROE is -0.19%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, SLGC is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check GDRX's competition here
Certara, Inc. (NASDAQ: CERT)
SLGC vs CERT Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CERT has a market cap of 1.3B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while CERT trades at $8.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CERT's P/E ratio is 20.38. In terms of profitability, SLGC's ROE is -0.19%, compared to CERT's ROE of -0.07%. Regarding short-term risk, SLGC is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check CERT's competition here
Teladoc Health, Inc. (NYSE: TDOC)
SLGC vs TDOC Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, TDOC has a market cap of 1.3B. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while TDOC trades at $6.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas TDOC's P/E ratio is -7.72. In terms of profitability, SLGC's ROE is -0.19%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, SLGC is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check TDOC's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
SLGC vs CCLDO Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CCLDO's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, SLGC is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
SLGC vs HSTM Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, HSTM has a market cap of 847.8M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while HSTM trades at $29.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas HSTM's P/E ratio is 35.83. In terms of profitability, SLGC's ROE is -0.19%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, SLGC is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check HSTM's competition here
Phreesia, Inc. (NYSE: PHR)
SLGC vs PHR Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, PHR has a market cap of 779.4M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while PHR trades at $12.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas PHR's P/E ratio is 45.04. In terms of profitability, SLGC's ROE is -0.19%, compared to PHR's ROE of +0.03%. Regarding short-term risk, SLGC is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check PHR's competition here
Claritev Corporation (NYSE: CTEV)
SLGC vs CTEV Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CTEV has a market cap of 719.4M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while CTEV trades at $42.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CTEV's P/E ratio is -2.48. In terms of profitability, SLGC's ROE is -0.19%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, SLGC is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check CTEV's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
SLGC vs SOPH Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SOPH has a market cap of 639.3M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while SOPH trades at $7.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SOPH's P/E ratio is -6.86. In terms of profitability, SLGC's ROE is -0.19%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, SLGC is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check SOPH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
SLGC vs MPLN-WT Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, SLGC is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
SLGC vs ACCD Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas ACCD's P/E ratio is -3.08. In terms of profitability, SLGC's ROE is -0.19%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, SLGC is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
SLGC vs SHCR Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SHCR's P/E ratio is -3.76. In terms of profitability, SLGC's ROE is -0.19%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, SLGC is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
SLGC vs EVH Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, EVH has a market cap of 525.3M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while EVH trades at $4.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas EVH's P/E ratio is 35.92. In terms of profitability, SLGC's ROE is -0.19%, compared to EVH's ROE of -0.99%. Regarding short-term risk, SLGC is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check EVH's competition here
NRC Health (NASDAQ: NRC)
SLGC vs NRC Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, NRC has a market cap of 480.3M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while NRC trades at $21.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas NRC's P/E ratio is 25.99. In terms of profitability, SLGC's ROE is -0.19%, compared to NRC's ROE of +0.48%. Regarding short-term risk, SLGC is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check NRC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
SLGC vs SLGCW Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, SLGC's ROE is -0.19%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, SLGC is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
SLGC vs TBRG Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas TBRG's P/E ratio is 9.37. In terms of profitability, SLGC's ROE is -0.19%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, SLGC is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
SLGC vs MPLN Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas MPLN's P/E ratio is -0.23. In terms of profitability, SLGC's ROE is -0.19%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, SLGC is more volatile compared to MPLN. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check MPLN's competition here
So-Young International Inc. (NASDAQ: SY)
SLGC vs SY Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SY has a market cap of 288.7M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while SY trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SY's P/E ratio is -6.67. In terms of profitability, SLGC's ROE is -0.19%, compared to SY's ROE of -0.16%. Regarding short-term risk, SLGC is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check SY's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
SLGC vs TRHC Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas TRHC's P/E ratio is -4.27. In terms of profitability, SLGC's ROE is -0.19%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, SLGC is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
SLGC vs SMFR Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SMFR's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, SLGC is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
SLGC vs SPOK Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SPOK has a market cap of 229.8M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while SPOK trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SPOK's P/E ratio is 18.33. In terms of profitability, SLGC's ROE is -0.19%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, SLGC is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
SLGC vs AMWL Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, AMWL has a market cap of 219.9M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while AMWL trades at $12.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas AMWL's P/E ratio is -2.93. In terms of profitability, SLGC's ROE is -0.19%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, SLGC is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check AMWL's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
SLGC vs OPRX Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, OPRX has a market cap of 164.8M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while OPRX trades at $8.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas OPRX's P/E ratio is 8.06. In terms of profitability, SLGC's ROE is -0.19%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, SLGC is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check OPRX's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
SLGC vs CPSI Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CPSI's P/E ratio is -183.80. In terms of profitability, SLGC's ROE is -0.19%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, SLGC is more volatile compared to CPSI. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check CPSI's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
SLGC vs HCAT Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, HCAT has a market cap of 129.3M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while HCAT trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas HCAT's P/E ratio is 8.75. In terms of profitability, SLGC's ROE is -0.19%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, SLGC is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check HCAT's competition here
Augmedix, Inc. (NASDAQ: AUGX)
SLGC vs AUGX Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas AUGX's P/E ratio is -4.99. In terms of profitability, SLGC's ROE is -0.19%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, SLGC is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
SLGC vs CCLD Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CCLD has a market cap of 104.1M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while CCLD trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CCLD's P/E ratio is 9.42. In terms of profitability, SLGC's ROE is -0.19%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, SLGC is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check CCLD's competition here
SCWorx Corp. (NASDAQ: WORX)
SLGC vs WORX Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, WORX has a market cap of 88M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while WORX trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas WORX's P/E ratio is -6.40. In terms of profitability, SLGC's ROE is -0.19%, compared to WORX's ROE of -0.65%. Regarding short-term risk, SLGC is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check WORX's competition here
Forian Inc. (NASDAQ: FORA)
SLGC vs FORA Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas FORA's P/E ratio is -24.11. In terms of profitability, SLGC's ROE is -0.19%, compared to FORA's ROE of -0.17%. Regarding short-term risk, SLGC is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check FORA's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
SLGC vs DH Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, DH has a market cap of 67.6M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while DH trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas DH's P/E ratio is 2.46. In terms of profitability, SLGC's ROE is -0.19%, compared to DH's ROE of -0.75%. Regarding short-term risk, SLGC is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check DH's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
SLGC vs CCLDP Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CCLDP's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, SLGC is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
SLGC vs ONMD Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, ONMD has a market cap of 44.3M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while ONMD trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas ONMD's P/E ratio is -5.18. In terms of profitability, SLGC's ROE is -0.19%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, SLGC is more volatile compared to ONMD. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
SLGC vs SNCE Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SNCE's P/E ratio is -0.27. In terms of profitability, SLGC's ROE is -0.19%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, SLGC is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
SLGC vs AKLI Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas AKLI's P/E ratio is -0.71. In terms of profitability, SLGC's ROE is -0.19%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, SLGC is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
SLGC vs SHLT Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SHLT's P/E ratio is -3.87. In terms of profitability, SLGC's ROE is -0.19%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, SLGC is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
SLGC vs SHCRW Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, SLGC's ROE is -0.19%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, SLGC is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
SLGC vs ONMDW Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, ONMDW has a market cap of 32M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while ONMDW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas ONMDW's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, SLGC is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
SLGC vs STRM Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas STRM's P/E ratio is -2.40. In terms of profitability, SLGC's ROE is -0.19%, compared to STRM's ROE of -0.65%. Regarding short-term risk, SLGC is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
SLGC vs RNLX Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas RNLX's P/E ratio is -0.33. In terms of profitability, SLGC's ROE is -0.19%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, SLGC is more volatile compared to RNLX. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
SLGC vs LIFW Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas LIFW's P/E ratio is -0.02. In terms of profitability, SLGC's ROE is -0.19%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, SLGC is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check LIFW's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
SLGC vs SCNX Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SCNX has a market cap of 18.9M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while SCNX trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SCNX's P/E ratio is -0.19. In terms of profitability, SLGC's ROE is -0.19%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, SLGC is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check SCNX's competition here
Babylon Holdings Limited (NYSE: BBLN)
SLGC vs BBLN Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas BBLN's P/E ratio is -0.04. In terms of profitability, SLGC's ROE is -0.19%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, SLGC is more volatile compared to BBLN. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check BBLN's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
SLGC vs BEATW Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, BEATW has a market cap of 12.5M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while BEATW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas BEATW's P/E ratio is -0.03. In terms of profitability, SLGC's ROE is -0.19%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, SLGC is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check BEATW's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
SLGC vs BFRG Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, BFRG has a market cap of 10.8M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while BFRG trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas BFRG's P/E ratio is -1.08. In terms of profitability, SLGC's ROE is -0.19%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, SLGC is more volatile compared to BFRG. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check BFRG's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
SLGC vs ETAO Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas ETAO's P/E ratio is -0.01. In terms of profitability, SLGC's ROE is -0.19%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, SLGC is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check ETAO's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
SLGC vs MGRX Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, MGRX has a market cap of 9M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while MGRX trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas MGRX's P/E ratio is -0.39. In terms of profitability, SLGC's ROE is -0.19%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, SLGC is more volatile compared to MGRX. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check MGRX's competition here
UpHealth, Inc. (NYSE: UPH-WT)
SLGC vs UPH-WT Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, SLGC is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check UPH-WT's competition here
UpHealth, Inc. (NYSE: UPH)
SLGC vs UPH Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas UPH's P/E ratio is -0.07. In terms of profitability, SLGC's ROE is -0.19%, compared to UPH's ROE of -1.05%. Regarding short-term risk, SLGC is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check UPH's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
SLGC vs PEAR Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas PEAR's P/E ratio is -0.08. In terms of profitability, SLGC's ROE is -0.19%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, SLGC is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
SLGC vs PEARW Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas PEARW's P/E ratio is -0.00. In terms of profitability, SLGC's ROE is -0.19%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, SLGC is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
SLGC vs OTRK Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas OTRK's P/E ratio is -0.02. In terms of profitability, SLGC's ROE is -0.19%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, SLGC is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check OTRK's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
SLGC vs HCTI Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, HCTI has a market cap of 2M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while HCTI trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas HCTI's P/E ratio is -0.22. In terms of profitability, SLGC's ROE is -0.19%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, SLGC is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
SLGC vs CMAX Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CMAX's P/E ratio is -0.00. In terms of profitability, SLGC's ROE is -0.19%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, SLGC is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
SLGC vs VSEEW Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, VSEEW has a market cap of 1.4M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, SLGC's ROE is -0.19%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, SLGC is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check VSEEW's competition here
Aclarion, Inc. (NASDAQ: ACON)
SLGC vs ACON Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while ACON trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas ACON's P/E ratio is -0.27. In terms of profitability, SLGC's ROE is -0.19%, compared to ACON's ROE of -0.59%. Regarding short-term risk, SLGC is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
SLGC vs LIFWZ Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, SLGC is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
SLGC vs EUDAW Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, SLGC's ROE is -0.19%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, SLGC is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check EUDAW's competition here
VSee Health, Inc. (NASDAQ: VSEE)
SLGC vs VSEE Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, VSEE has a market cap of 816.5K. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while VSEE trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas VSEE's P/E ratio is -0.10. In terms of profitability, SLGC's ROE is -0.19%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, SLGC is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check VSEE's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
SLGC vs MSPRZ Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, SLGC is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
SLGC vs KERN Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas KERN's P/E ratio is -0.01. In terms of profitability, SLGC's ROE is -0.19%, compared to KERN's ROE of -0.20%. Regarding short-term risk, SLGC is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
SLGC vs KERNW Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas KERNW's P/E ratio is -0.00. In terms of profitability, SLGC's ROE is -0.19%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, SLGC is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
SLGC vs LIFWW Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas LIFWW's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, SLGC is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
SLGC vs CMAXW Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CMAXW's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, SLGC is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check CMAXW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
SLGC vs ZCMD Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, ZCMD has a market cap of 35.3K. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while ZCMD trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, SLGC's ROE is -0.19%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, SLGC is more volatile compared to ZCMD. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check ZCMD's competition here
Aclarion, Inc. (NASDAQ: ACONW)
SLGC vs ACONW Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, ACONW has a market cap of 16K. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas ACONW's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, SLGC is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check ACONW's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
SLGC vs WGSWW Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, WGSWW has a market cap of 5.8K. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas WGSWW's P/E ratio is -0.00. In terms of profitability, SLGC's ROE is -0.19%, compared to WGSWW's ROE of -0.39%. Regarding short-term risk, SLGC is more volatile compared to WGSWW. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check WGSWW's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
SLGC vs CHNG Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CHNG's P/E ratio is -152.72. In terms of profitability, SLGC's ROE is -0.19%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, SLGC is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check CHNG's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
SLGC vs CNVY Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CNVY's P/E ratio is -71.50. In terms of profitability, SLGC's ROE is -0.19%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, SLGC is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check CNVY's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
SLGC vs MTBCP Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas MTBCP's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, SLGC is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check MTBCP's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
SLGC vs KURIU Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, KURIU has a market cap of 0. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas KURIU's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, SLGC is more volatile compared to KURIU. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check KURIU's competition here
CareCloud, Inc. (NASDAQ: MTBC)
SLGC vs MTBC Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas MTBC's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, SLGC is more volatile compared to MTBC. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check MTBC's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
SLGC vs MSPRV Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas MSPRV's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to MSPRV's ROE of N/A. Regarding short-term risk, SLGC is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check MSPRV's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
SLGC vs SMFRW Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SMFRW's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, SLGC is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check SMFRW's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
SLGC vs IMS Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, IMS has a market cap of 0. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas IMS's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to IMS's ROE of +0.27%. Regarding short-term risk, SLGC is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check IMS's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
SLGC vs CHNGU Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CHNGU's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, SLGC is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check CHNGU's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
SLGC vs NAVA Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas NAVA's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, SLGC is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for SLGC.Check NAVA's competition here
NantHealth, Inc. (NASDAQ: NH)
SLGC vs NH Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, NH has a market cap of 0. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas NH's P/E ratio is -0.12. In terms of profitability, SLGC's ROE is -0.19%, compared to NH's ROE of +0.35%. Regarding short-term risk, SLGC is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for SLGC.Check NH's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
SLGC vs AFFX Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas AFFX's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, SLGC is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check AFFX's competition here
Cerner Corporation (NASDAQ: CERN)
SLGC vs CERN Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CERN has a market cap of 0. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CERN's P/E ratio is 55.84. In terms of profitability, SLGC's ROE is -0.19%, compared to CERN's ROE of +0.14%. Regarding short-term risk, SLGC is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check CERN's competition here
Castlight Health, Inc. (NYSE: CSLT)
SLGC vs CSLT Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CSLT's P/E ratio is -37.27. In terms of profitability, SLGC's ROE is -0.19%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, SLGC is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check CSLT's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
SLGC vs MTBCO Comparison August 2026
SomaLogic, Inc. (NASDAQ: SLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, SLGC is priced at $2.10 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas MTBCO's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, SLGC is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for SLGC.Check MTBCO's competition here